Tagged with Biotech,

France Genethon, a laboratory created by the patient organization AFM-Telethon, is one of the world’s leaders in the development of biotherapies for rare diseases. In this interview Genethon’s CEO Frédéric Revah explains its role in the discovery of innovative therapies since the 1990s and the recent launch of YposKesi, its innovative…

France Key statistics on the workforce, revenue, investment levels, R&D spending and consumption in the French pharmaceutical industry today. Mapping the 32 biopharma production sites in France, including the location, company and products produced. France ranks fourth in the EU for pharma production with EUR 20.981 billion in value, behind Switzerland,…

France Didier Geneau provides a fascinating insight into the French biotech scene; its strengths but also weaknesses. France has an incredible track-record of excellence in innovation and, for the first time in a long time, true government backing. All the ingredients are there to excel even further in biotech innovation. Now,…

BIOTECH This week the NHS becomes the first in the world to routinely offer access to breakthrough genomic medicine. Today (1st October 2018) marks a huge stride in ‘precision medicine’ in the UK as the NHS begins to offer gene therapies tailored to individual patients. Hospitals across England have connected to specialist…

Hong Kong Prof. Michael Yang, an accomplished scientist and start-up expert, introduces the goals of the fast-growing Biomedical Sciences Department of City University Hong Kong. He unveils the contribution of Hong Kong to the Greater Bay Area in the biomedical field, while analyzing the key elements to change so the region can…

USA Theranos the US biotech start-up is to be dissolved after bad-blood tests exposed. Theranos was set up in Silicon Valley in 2004 by 19-year-old founder Elizabeth Holmes who was considered as a young trailblazer in the biotech industry. She was a student at Stanford University when she imagined the idea for…

Hong Kong Gene Shigekawa, managing partner of MAZ World, shares their recent move to the Hong Kong Science and Technology Park (HKSTP) in 2017, the revolutionary ostrich-derived antibody they hope to further develop and commercialize, the strengths of Hong Kong as a biotech base for start-ups, and the huge potential for their…

GSK KaNDy Therapeutics, a UK-based biotech has raised £25 million to finance the Phase 2b trial of their breakthrough product in Women’s Health. Our investors and the KaNDy management team are united by the common belief that NT-814 has the potential to be a transformational treatment for the millions of women worldwide…

Hong Kong Professor Hon-Ming Lam, a renowned scientist specializing in soybean genomics, shares his passion for his research, the importance of soybeans to China’s future environmental and growth sustainability, his insights on Hong Kong’s ambition to become an innovation and technology hub, and his perspective on how government, industry and academics should…

UK Heading FUJIFILM Diosynth Biotechnologies’ operations globally, Steve Bagshaw speaks out about the excellence of science in the UK and how it fits the company’s plans to build up a solid presence in the development and manufacturing of new advanced treatments. He further explains how the company has been able to…

UK Chief Executive since 2011, Peter Coleman introduces Cobra Biologics and highlights challenges both domestically and globally in the biotech space for CDMOs; he addresses funding opportunities within the public and private sector and Cobra Biologics’ ambitious plans for 2022. Can you please introduce Cobra Biologics to our international readers? “The…

UK Adaptimmune, a British-based biotech company born out of the University of Oxford has a solid research base in the UK and manufactures its T-Cells in the US. Its CEO, James Noble, shares Adaptimmune’s story and explains why regulatory support is essential in a field as complex and novel as T-Cell…